https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
Hematopoietic stem cell transplantation (HSCT) is a curative treatment for most hematologic diseases. To evaluate the level of donor engraftment, chimerism must be carefully monitored after HSCT. Short tandem repeats, quantitative PCR (qPCR), and, more recently, digital PCR (dPCR) are widely used to determine the proportions of donor and recipient cells after HSCT. The screening and quantification of chimerism have been evaluated by 2 new methods a ready-to-use next-generation sequencing (NGS)-based method using the Devys
Like
Comment
Share
